StockData
GRI Bio, Inc. logo

GRI Bio, Inc. (GRI) stock

GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.27−0.08 (-5.95%)

Close on Nov 18, 2026Market cap $2.78MP/E –Yield –

GRI Bio profit margin

Profit margin (net margin) is net income as a percentage of revenue.

GRI Bio's profit margin for the twelve months ending Dec 31, 2020 was -4822.0%. For fiscal 2020 it was -4822.0%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020-4822.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2020Mar 31, 2020-1161.0%–

More GRI Bio figures

See a number that looks wrong?